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Abbreviations: HBV, hepatitis B virus; DHBV, duck hepatitis B virus; DpreS, duck pres 
domains; PC, egg phosphatidylcholine; PG, phosphatidylglycerol; DMPC, 
dimyristoylphosphatidylcholine; DMPG,  dimyristoylphosphatidylglycerol; NBD-PE, N-(7-
nitro-2,1,3-benzoxadiazol-4-yl)-dimyristoylphosphatidylethanolamine; Rh-PE, N-(lissamine 
rhodamine B sulfonyl)-diacylphosphatidylethanolamine; ANTS, 8-Aminonaphtalene-1,3,6-
trisulfonic acid; DPX, p-xylenebis(pyridinium) bromide; DPH, 1,6-diphenyl-1,3,5-hexatriene 
(DPH); TMA-DPH, 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene; NBD-F, 4-
fluoro-7-nitrobenz-2-oxa-1,3-diazole; CD, circular dichroism; CCA, convex constraint 
analysis 
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ABSTRACT 
 
In order to shed light on the hepatitis B virus fusion mechanism and to explore the 
fusogenic capabilities of preS regions, a recombinant duck hepatitis B virus preS protein 
(Dpres) containing six histidines at the carboxy-terminal end has been obtained. The DpreS 
domain, which has an open and mostly non-ordered conformation as indicated by 
fluorescence and circular dichroism spectroscopies, has the ability to interact with negatively 
charged phospholipid vesicles. The observed interaction differences between neutral and 
acidic phospholipids can be interpreted in terms of an initial ionic interaction between the 
phospholipid polar head group and the protein followed by the insertion of, probably the N-
terminal region, in the cellular membrane. Fluorescence polarization studies detect a decrease 
of the transition enthalpy together with a small modification of the transition temperature, 
typical effects of integral membrane proteins. The interaction of the protein with acidic 
phospholipid vesicles induces aggregation, lipid mixing and leakage of internal contents, 
properties which have been adscribed to membrane destabilizing proteins. The fact that the 
preS domains of the hepadnaviruses have little similarity but share a very similar hydrophobic 
profile, points to the importance of the overall three-dimensional structure as well as to its 
conformational flexibility and the distribution of polar and apolar amino acids on the 
expression of their destabilizing properties rather than to a particular amino acid sequence. 
The results presented herein argue for the involvement of Dpres in the initial steps of DHBV 
infection. Taken together with previously reported results, the conclusion that both S and preS 
regions participate in the fusion process of the hepadnaviridae family may be drawn.  
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Hepatitis B virus (HBV) belongs to the Hepadnaviridae family which also includes 
viruses isolated from mammals (orthohepadnavirus) and birds (avihepadnavirus). All of these 
viruses are species and cell type specific and show similar genomic organization and 
replication processes. The study of the initial steps of HBV infection has been difficult due to 
the lack of a suitable infection system. Even though, in the case of Duck Hepatitis B Virus 
(DHBV), primary cultures of duck hepatocytes can be infected by DHBV, the entry of DHBV 
into target cells is still poorly understood.  In the last few years it has been postulated that 
hepadnaviruses enter hepatocytes via endocytic pathways. In the case of DHBV, the 
carboxypeptidase D, a Golgi-resident protein, has been postulated to be the receptor for avian 
hepadnaviruses 
1, 2
. Because of ubiquitous distribution of this protein, other factors must be 
involved in host specificity. Thus, the glycine decarboxylase, whose expression is restricted to 
the liver, kidney and pancreas that are susceptible to DHBV infection, has been also 
postulated as a virus receptor 
3
. Following receptor attachment, DHBV has been shown to 
take the endocytic route involving early endosomes
4
 or enters the late-endosome compartment 
5
. However, several other receptor candidates able to bind to both S and preS domains have 
been described for HBV 
6, 7
. 
Both in viral and subviral particles of DHBV, there are two main different surface 
proteins which are not glycosylated: S, with 167 amino-acids and 18 kDa, and L, 36 kDa, 
with an additional 161 amino-acid sequence in the amino-terminal end, the preS domain 
(DpreS). Both of these proteins are necessary for infection 
8
. A third 10 kDa membrane 
protein, St, has been observed. This protein consists of the transmembrane fragment 1 of S 
protein, the internal cystein loop and a part of transmembrane fragment 2, which could act as 
a chaperone for the folding of the L protein 
9
. The preS domain of DHBV envelope protein 
has been implicated in a wide number of functions in the virus life cycle because of the 
different topologies that it can adopt. Thus, external DpreS may bind to a putative hepatocyte 
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receptor and induce virus entry into endosomes 
10
. Also, it has been postulated that there is a 
conformational change of L which may be part of the fusion process when the preS domain 
possesses an intermediate orientation between an internal and external topology 
11
. 
Little is known about the role of the different envelope proteins in the viral fusion 
mechanism. In HBV, a peptide comprising the 16 amino acids at the N-terminus of S protein 
has been shown to interact with model membranes, promoting liposome destabilization in a 
pH-dependent manner and adopting an extended conformation during the process 
12, 13
. The 
destabilization properties observed for the HBV fusion peptide could be extended to other 
members of the hepadnavirus family, such as DHBV and woodchuck hepatitis B virus 
5, 14
. 
Evidence for the role of the N-terminal S peptide in fusion has also been obtained by others 
15, 
16
 who suggest that the exposure of this consensus fusion motif is important in hepadnavirus 
entry. The HBV preS domain is involved in the fusion of this virus with the plasma 
membrane of target cells. It was shown to be able to interact in a monomeric way with acidic 
phospholipid vesicles, to induce aggregation, lipid mixing and release of internal contents of 
acidic vesicles resulting in a protein conformational change which increases the helical 
content 
17
. Moreover, a structural motif at the carboxy-terminal end of preS2 has been 
suggested to be involved in HBV entry 
18
 although it seems not to be essential for infectivity 
19-21
. These results suggest that preS could contribute, together with the N-terminal S peptide, 
to the fusion of viral and cellular membranes. 
In order to explore the fusogenic capabilities of DpreS region, a recombinant preS 
domain from DHBV, produced in E. coli cells, was used in membrane interaction studies. 
In this paper we describe that the preS domain is able to interact mainly with acidic 
phospholipid vesicles and to destabilize these membrane model systems. 
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MATERIALS AND METHODS 
 
Reagents. N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-dimyristoylphosphatidylethanolamine (NBD-
PE), N-(lissamine rhodamine B sulfonyl)-diacylphosphatidylethanolamine (Rh-PE), 
dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylglycerol (DMPG) were 
provided by Avanti Polar Lipids. Egg phosphatidylcholine (PC) and phosphatidylglycerol 
(PG) were obtained from Sigma. 8-Aminonaphtalene-1,3,6-trisulfonic acid (ANTS), p-
xylenebis(pyridinium) bromide (DPX), 1,6-diphenyl-1,3,5-hexatriene (DPH),  1-(4-
trimethylammoniumphenyl)-6-phenyl-1,3,5-hexatriene (TMA-DPH) and 4-fluoro-7-
nitrobenz-2-oxa-1,3-diazole (NBD-F) were purchased from Molecular Probes. Triton X-100 
was obtained from Boehringer Mannheim. Sepharose CL-6B Ni-nitrilotriacetic acid (NTA) 
was purchased from Qiagen. All other reagents were obtained from Merck and Sigma. All 
solvents were of HPLC grade. 
 
Cloning, expression and purification of DpreS-his domains. The cloning, expression and 
purification processes were similar to those described for the preS domain of HBV 
22
 with 
some modifications. The preS domain of DHBV was amplified by PCR using DHBV DNA 
contained in the plasmid pGEM4 DpreS as template and ligated into the pET21b (Novagen) 
expression vector that adds a six-histidine sequence at the carboxy-terminal end of the 
protein. The PCR reaction conditions were: 1 minute at 94 ºC, followed by 5 cycles at 94 ºC, 
60 ºC and 72 ºC, each for 1 min, by 30 cycles at 94 ºC, 55 ºC and 72 ºC, each for 1 min, and a 
final “filling in” step at 72 ºC for 7 min. The product of the PCR reaction was run on an 
agarose gel (0.8%), stained with a 1 µg/ml ethidium bromide solution for 15 min, visualized 
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under UV light and extracted using the Qiaex DNA extraction kit (Qiagen). The primers used 
in the reaction were:  
 
DpreS-NdeI(+): 5'acattt  cat  ATG GGG CAA CAT CCA GCA AAA 
DpreS-EagI(-):  5'gaaggtaccggccgt TTT CTT CTT CAA GGG 
 
They were designed in such a way that the PCR product had a NdeI restriction site 
(CATATG) at the 5´ end and an EagI restriction site (CGGCCG) at the 3´ end (shown 
underlined). The lowercase letters correspond to the region that hybridize with the plasmid 
pGEM4-DpreS (DpreS-NdeI(+)) or with the S domain (DpreS-EagI(-)). 
The AmpliTaq-Gold DNA Polymerase (Roche) used adds a dTPA in the 3´end, so the 
PCR product was cloned into the linear plasmid pGEM-T (Promega) with 3´T, then digested 
with NdeI and EagI enzymes (New England Biolabs, 10 U/µl) and cloned into the pET21b 
plasmid, digested with the same enzymes. The cDNA sequence was confirmed by automated 
DNA sequencing. The resulting plasmid was called pET21b-DpreS. 
Escherichia coli strains HMS174 (DE3) or Tuner (Novagen) were transformed with 
pET21b-DpreS and plated on LB containing 50 µg/mL ampicillin. In these cells, the T7-
polymerase gene is under the control of the isopropyl β-D-thiogalactopyranoside (IPTG)-
inducible lacUV5 promoter. A single colony was selected and used to inoculate 50 mL of M9 
medium supplemented with 0.17% glucose, 1.06 mM MgSO4, 0.053 mM CaCl2, and 100 
µg/mL ampicillin. Following overnight incubation at 37 ºC, the culture was used to inoculate 
1 L of fresh M9 medium. This culture was grown to an optical density at 600 nm of 0.6 and 
then IPTG (Sigma) was added to a final concentration of 0.5 mM and incubated at 30 ºC for 4 
h, to induce protein expression. The time and temperature of induction were optimized to 
reduce protein hydrolysis. Cells were harvested by centrifugation at 7400 g for 10 minutes in 
Page 7 of 47
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a GS-3 rotor (Sorvall) and the cell pellet was resuspended in ice cold 10 mM MOPS pH 8.0, 
10 mM Imidazole, 0.3 M NaCl, 6 M Urea. Cells were lysed by tip sonication and centrifuged 
at 89500 g for 30 min in a Beckman SW-28 rotor.  
Recombinant protein was purified using a single affinity chromatography step in 
Sepharose CL-6B Ni-nitrilotriacetic acid (NTA) column (Qiagen) equilibrated with 10 mM 
MOPS pH 8.0, 10 mM Imidazole, 0.3 M NaCl, 6 M Urea. DpreS-his recombinant protein was 
eluted with 10 mM MOPS pH 8.0, 200 mM Imidazole, 0.3 M NaCl, 6 M Urea. The urea was 
removed by dialysis against 10 mM MOPS, pH 7.0. The presence of DpreS-his was 
monitored throughout the purification by SDS-PAGE. Amino acid composition and protein 
concentration were determined by amino acid analysis performed on a Beckman 6300 
automatic analyzer. 
 
Spectroscopic Characterization of DpreS-his. Circular dichroism spectra were recorded on 
a Jasco J-715 spectropolarimeter equipped with a thermostated cell. The protein concentration 
was 0.1 mg/mL (far-UV) or 1 mg/mL (near-UV). The buffer used was 10 mM MOPS pH 7.0. 
A minimum of three spectra were accumulated for each sample and the contribution of the 
buffer was subtracted. Values of mean residue ellipticity were calculated on the basis of 110 
as the average molecular mass per residue and they are reported in terms of [θ]M.R.W (degrees 
x cm
2
 x dmol
-1
). The secondary structure of the protein was evaluated by computer fit of the 
dichroism spectra according to the algorithm convex constraint analysis (CCA) 
23
. This 
method relies on an algorithm that calculates the contribution of the secondary structure 
elements that give rise to the original spectral curve without referring to spectra from model 
systems. 
Fluorescence studies were performed on a SLM Aminco 8000C spectrofluorimeter. 
The protein concentration was 0.05 mg/mL. The buffer used was 10 mM MOPS pH 7.0. At 
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least three spectra were accumulated and the contribution of the buffer was subtracted. 
Excitation was performed at a wavelength of 275 or 295 nm, and emission spectra measured 
over the range of 285-465 nm. The tyrosine contribution to the emission spectra was 
calculated by subtracting from the emission spectra measured at λexc = 275 nm the emission 
spectra measure a λexc = 295 nm multiplied by a factor. The factor was obtained from the ratio 
between the fluorescence intensities measured with λexc = 275 nm and λexc = 295 nm at 
wavelengths higher than 380 nm, where there is no tyrosine contribution. 
 
Labeling of DpreS-his domains. Fluorescent labelling of the N-terminus of the protein was 
achieved following the procedure described by Rapaport and Shai 
24
. Briefly, DpreS-his 
protein was incubated at pH 6.8 with a ten molar excess of NBD-F at room temperature for 4 
h. Unbound NBD-F was removed by means of a PD-10 column. Labelling of the protein 
could be monitored by the appearance of a maximum at 467 in the absorbance spectrum, 
which was used to determine the labelling ratio. The NBD and protein concentrations were 
determined by using 20000 M
−1
 cm
−1
 as the molar extinction coefficient of NBD-PE and 
amino acid analysis, respectively. 
 
Vesicle preparation. In all cases a lipid film was obtained by drying chloroform: methanol 
(2:1) solution of the lipid under a current of nitrogen and this film was further kept under 
vacuum for 4–5 h to completely remove the organic solvent. The phospholipids were 
resuspended at a concentration of 1 mg/ml in medium buffer (100 mM NaCl, 5 mM MES, 5  
mM sodium citrate, 5 mM Tris, 1 mM EDTA) at the appropriate pH value and incubated at 37 
°C for 1 h and eventually vigorously vortexed. This suspension was sonicated in a bath 
sonicator (Branson 1200) for 15 min and was subsequently subjected to fifteen cycles of 
Page 9 of 47
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extrusion in a LiposoFast-Basic extruder apparatus (Avestin, Inc.) with 100-nm polycarbonate 
filters (Costar).  
 
Binding assay. Binding experiments were conducted as previously described 
24
. In order to 
determine the degree of NBD-DpreS-his association with phospholipid vesicles, PC or PG 
vesicles were added to a fixed amount of labeled protein (0.03-0.06 µM) in medium buffer at 
the desired pH and incubated at 37 °C for 1-2 min. Fluorescence spectra between 480 and 650 
nm were registered in a SLM AMINCO 8000C spectrofluorimeter (SLM Instruments) with 
excitation wavelength set at 467 nm. A minimum of three spectra were accumulated for each 
sample. In order to obtain the fluorescence maximum in the presence of lipids, a saturating 
condition has been employed (molar lipid:protein ratio of 4600:1) to avoid the contribution of 
the free protein to the emission spectrum.  
The fluorescence intensity registered at 530 nm at different lipid/protein molar ratios 
was utilized to obtain the binding isotherm. In order to obtain the partition coefficient, data 
were analyzed using the equation: 
Xb= Kp·Cf 
where Xb is the molar ratio of bound protein per total lipid, Kp corresponds to the partition 
coefficient and Cf represents the equilibrium concentration of free protein in solution. It was 
assumed that proteins only partitioned over the outer leaflet of vesicles. Therefore, Xb values 
were corrected as Xb
*
=Xb/0.5 and the data analyzed as: 
Xb
*
= Kp
*
·Cf 
Values of the corrected partition coefficient, Kp
*
, were determined from the initial 
slopes of the binding isotherms. In order to calculate Xb, we estimated F∞, the fluorescence 
signal obtained with a saturating phospholipid concentration by extrapolating from a double 
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reciprocal plot of F (total protein fluorescence) versus CL (total lipid concentration). At every 
phospholipid concentration, the fraction of bound protein can be calculated by the formula: 
fb = (F− F0)/(F∞−F0) 
where F0 represents the fluorescence of unbound protein and F∞ the fluorescence of bound 
protein. In all cases, fluorescence from control vesicles in the absence of labeled protein was 
subtracted. At least three different experiments were performed for each condition. 
 
Fluorescence polarization. Fluorescence polarization measurements of the probes 1,6-
diphenyl-1,3,5-hexatriene (DPH) and 1-(4-trimethylammoniumphenyl)-6-phenyl-1,3,5-
hexatriene (TMA-DPH) were taken in the SLM AMINCO 8000C spectrofluorimeter by using 
10 mm Glan-Thompson polarizers. DMPG and DMPC vesicles (0.14 mM) were prepared as 
indicated above containing DPH or TMA-DPH at a weight ratio of 1:500 or 1:100, 
respectively. The protein-vesicle mixtures were incubated at 37 °C for 30 min. The excitation 
was set at 365 nm and emission was measured at 425 nm, after equilibration of the samples at 
the indicated temperature. The temperature in the cuvette was maintained with a circulating 
water bath. A minimum of three different experiments were performed for each condition 
tested. 
 
Vesicle aggregation. The increase in the optical density at 360 nm (∆OD360) produced by 
addition of DpreS-his protein to a phospholipid vesicle suspension, in medium buffer at the 
appropriate pH, was measured on a Beckman DU-7 spectrophotometer after incubation at 37 
°C for 1 h. Values of control samples containing only vesicles and only protein were 
subtracted at each protein concentration. The final phospholipid concentration was kept at 60 
µM. At least three different experiments were performed for each condition. 
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Lipid mixing. Lipid mixing was monitored by using the fluorescent probe dilution assay 
25
 in 
which the decrease in the efficiency of the fluorescence energy transfer between NBD-PE 
(energy donor) and Rh-PE (energy acceptor) incorporated into liposomes, as a consequence of 
lipid mixing, is measured. Liposomes, in medium buffer at the appropriated pH, labeled with 
1 mol % NBD-PE and 1 mol % Rh-PE were mixed with unlabeled liposomes in a 1:9 molar 
ratio. After incubation of liposomes with the DpreS domains at different concentrations at 37 
°C for 1 h, emission spectra were recorded with excitation wavelength set at 450 nm. Both the 
excitation and emission slits were set at 4 mm. The excitation polarizer was kept constant at 
90° and the emission polarizer was kept constant at 0° to minimize dispersive interference. 
The efficiency of the energy transfer was calculated from the ratio of the emission intensities 
at 530 and 590 nm and the appropriated calibration curve. The final phospholipid 
concentration was 0.14 mM. The organic solvent itself had no effect on the efficiency of the 
energy transfer. At least three different experiments were performed for each condition. 
 
Release of aqueous contents. Leakage was determined by the ANTS/DPX assay 
26
, which is 
based on the dequenching of ANTS fluorescence caused by its dilution upon release of the 
aqueous contents of one vesicle preparation containing both ANTS and DPX. It was 
performed by coencapsulating 12.5 mM ANTS and 45 mM DPX in 10 mM Tris, 20 mM 
NaCl, pH 7.2, in phospholipid vesicles. The lipid film was hydrated as described previously 
and the vesicles were sonicated for 30 min. Afterwards vesicles were subjected to five cycles 
of freeze-thawing in liquid nitrogen and passed 15 times through a Liposo Fast-Basic extruder 
apparatus (Avestin, Inc.) with 100-nm polycarbonate filters (Costar). After the vesicles with 
the coencapsulated probe and quencher were formed, the whole sample was passed through a 
Sephadex G-75 column (Pharmacia) to separate the vesicles from the non encapsulated 
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material using medium buffer for elution. Assays were performed at a phospholipid 
concentration of 0.1–0.14 mM in medium buffer at the appropriated pH, by incubating with 
different amounts of protein at 37 °C for 1 h and measuring in the SLM Aminco 8000C 
spectrofluorimeter. The excitation wavelength was set at 385 nm and the ANTS emission was 
monitored at 520 nm. Both the excitation and emission slits were set at 4 mm. The excitation 
and emission polarizers were kept constant at 90° and 0°, respectively, to minimize 
interference due to dispersion. The fluorescence scale was set to 100% by addition of 0.5% 
Triton X-100, and 0% leakage was obtained measuring the fluorescence of control vesicles 
without protein. A minimum of three different experiments were performed for each 
condition tested. 
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RESULTS 
 
Cloning, Expression and Purification of DpreS-his. The cDNA of DpreS-his domain was 
cloned in the plasmid pET21b at the NdeI/EagI sites to yield pET21b-DpreS as described in 
Materials and methods. The cDNA sequence was confirmed by automated sequencing.   
Plasmid DNA from a colony containing the correct construct was purified and 
transformed into E. coli HMS174 (DE3) cells that were grown and harvested as described 
under Materials and methods. Protein expression was induced with IPTG 0.5 mM at 30 ºC for 
4 h (Figure 1A, lane 3). After lysing the cells in 10 mM MOPS pH 8.0, 10 mM Imidazole, 0.3 
M NaCl, 6 M Urea, most of the DpreS-his remained in the centrifuged supernatant (Figure 
1A, lane 5). This supernatant was applied to a Ni-NTA column equilibrated with the same 
buffer. Protein was eluted with 10 mM MOPS pH 8.0, 200 mM Imidazole, 0.3 M NaCl, 6 M 
Urea. As it can be observed in Figure 1A, lane 8, the purified protein was partly hydrolyzed. 
Thus, in order to reduce DpreS-his proteolysis, the plasmid was transformed into Tuner cells 
(Novagen) and the protein expression was induced with 0.5 mM IPTG at 30 ºC for 2 h (Figure 
1B). The purification process was carried out under denaturing conditions because it was 
observed that DpreS-his domains precipitate at concentrations higher than 1 mg/mL. 
Therefore, after elution, the protein was diluted to approximately 1 mg/mL and dialyzed 
against 10 mM MOPS pH 7.0 to remove urea. Under these conditions 15-20 mg of highly 
pure and stable protein were obtained per liter of cell culture (Figure 1B, lane 7).  
The protein was shown to be pure by SDS-PAGE, with an electrophoretic mobility 
close to that expected from its theoretical molecular mass, 19224 Da. The amino acid 
composition was also indicative of the purity of the protein since it was almost identical to 
that calculated from the amino acid sequence derived from the DNA sequence (Table 1), 
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taking into account that the cloning strategy added five additional amino acids (TAALE) to 
the carboxy-terminal end of DpreS just before the six histidine tag.  
 
Spectroscopic Characterization of DpreS-his. The far-UV CD spectrum of the recombinant 
DpreS-his protein at pH 7.0 is depicted in Figure 2A. It showed a minimum at 200 nm and a 
shoulder at 220 nm, indicative of a high content of non-ordered secondary structure. The 
assignment of the secondary structure elements according to the algorithm CCA 
23
 is shown 
in Table 2. Half of DpreS-his residues are in aperiodic secondary structure being β-sheet the 
major repetitive ordered secondary structure component (16%). On the other hand, the 
positive band observed in the near-UV CD spectra of DpreS-his (Figure 2B) indicates an 
asymmetric environment of the aromatic residues of the protein in the three-dimensional 
structure. The magnitude and the shape of the spectra observed at both pH 7.0 and 5.0 were 
similar (data not shown).  
More information about the three dimensional structure of the recombinant protein 
was obtained from the fluorescence emission spectrum (Figure 3). When exciting at either 
275 or 295 nm the recombinant protein exhibited a maximum centered at 344 nm, both at pH 
7.0 and 5.0, indicating that all Trp residues are in a highly hydrophilic environment very 
exposed to the solvent. The tyrosine contribution, calculated as described in Materials and 
methods, is almost negligible and very different from that expected for a mixture of Trp and 
Tyr in the ratio 4:2 of recombinant DpreS-his, probably due to resonance energy transfer from 
Tyr residues to nearby Trp residues or to quenching by other nearby amino acids.  
 
Interaction with phospholipids. Fluorescent labelling of DpreS-his was carried out 
following the procedure described in Materials and methods. The extent of labelling was 
calculated from the absorbance spectrum of NBD-DpreS-his. The reaction with NBD-F 
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resulted in the incorporation of one molecule of NBD to the protein. Taking into account that 
the reaction was carried out at pH 6.8, it is likely that the α-amino group, and not the Lys side 
chain, is the main labelling target 
24
. The emission spectrum of NBD-DpreS-his showed an 
emission maximum centered at 548 nm, both at pH 7.0 and pH 5.0 (Figure 4), which reflects a 
hydrophilic environment for the NBD moiety 
27
.  
The position of the fluorescence emission maximum exhibited by the NBD-DpreS-his 
upon binding to phospholipid vesicles provides information on the relative location of the 
NBD moiety and hence of the protein N-terminus. Upon interaction with PG vesicles at 
saturating conditions (molar lipid:protein ratio of 4600:1), to avoid the contribution of the free 
protein to the emission spectrum, the maximum was shifted to 528 nm, both at pH 5.0 (Figure 
4A) and pH 7.0 (Figure 4B), although the increase in fluorescence was lower at neutral pH. 
The observed blue shift reflects a relocation of the NBD group into a more hydrophobic 
environment in the presence of negatively charged phospholipids. When neutral 
phospholipids, PC, were used no changes in the position of the maximum nor in the 
fluorescence intensity were observed (Figure 4). 
In order to calculate the extent of binding, labeled protein at a final concentration of 
0.03-0.06 µM was titrated with increasing amounts of PG or PC vesicles. The mixtures were 
incubated at 37 °C for 2 min and the fluorescence intensity was measured at 530 nm. The 
protein concentration was low enough to avoid vesicle aggregation. The measured 
fluorescence at 530 nm, after subtracting the contribution of control experiments performed 
by titrating unlabeled proteins with the same vesicle concentration, was plotted against the 
phospholipid concentration (Figure 5). After incubation with PG, there is a significant 
increase in the fluorescence intensity either at pH 5.0 (Figure 5A) or pH 7.0 (Figure 5B), with 
the effect observed at acidic pH being higher. However, after incubation with PC the increase 
in fluorescence was almost negligible (Figure 5). 
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From this data, binding isotherms were obtained (Figure 6). Both at pH 5.0 and pH 7.0 
the data showed a non-linear behaviour. From a threshold concentration of free protein, Cf, a 
sharp increase in the slope was observed. The partition coefficients, reflecting the binding 
constants, were calculated as the slopes at the initial intervals (Figure 6, inset), being 1.9 x 10
4
 
M
-1
 and 2.8 x 10
4
 M
-1 
for pH 7.0 and 5.0 respectively. No partition coefficients could be 
calculated in the presence of PC. 
To study the involvement of a hydrophobic component in the interaction with 
phospholipids, the effect of DpreS-his on the thermotropic behaviour of DMPG and DMPC 
vesicles was measured by fluorescence depolarization. Liposomes, labeled in the hydrophobic 
core of the bilayer with the fluorescent probe DPH, were incubated with different DpreS-his 
concentrations, both at pH 7.0 and pH 5.0. The addition of DpreS-his to DMPG vesicles 
induced a decrease in the phase transition amplitude in a protein concentration-dependent 
manner with a minimal variation of 2 ºC of the phase transition temperature (Figure 7). 
DpreS-his affected almost exclusively the fluorescence polarization values at temperatures 
above the transition temperature, indicating that the proteins altered mainly the acyl chains in 
the liquid–crystal phase, inducing a higher order in the chain packing. The presence of DpreS-
his up to a molar protein:lipid ratio of 1:20 did not modify neither the transition temperature 
nor the phase transition amplitude of DMPC vesicles. The fact that only acidic phospholipids 
vesicles were distorted points to the electrostatic interactions as a crucial determinant of the 
lipid-protein interaction. As it is observed in the insets of Figure 7, the fluorescence 
polarization measured at 37.5 °C increased linearly up to a protein to lipid ratio of 0.02-0.03, 
remaining almost constant from this point. This value indicates that each molecule of protein 
prevents the transition phase of approximately 30-50 molecules of phospholipid. 
The alteration of the thermotropic behaviour of these phospholipids was also studied 
with the fluorescent probe TMA-DPH. This probe interacts with the polar head of the 
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phospholipids and gives information mainly from the outer monolayer. The results obtained 
were very similar to those described above for DPH (Figure 7C and D).  
 
Effect of phospholipid vesicles on the secondary structure of DpreS-his. The circular 
dichroism spectra of DpreS-his in the presence of PG vesicles are depicted in Figure 8. At pH 
5.0 and low phospolipid concentration (up to a protein:lipid ratio of 1:10) there is an increase 
in the ellipticity value probably due to the aggregation of the protein in the outer layer of the 
vesicles. At lower protein:lipid ratios, from 1:20 to 1:50, the ellipticity values decreased with 
a shift of the minimum from 200 to 209 nm and the appearance of a shoulder at 225 nm, 
characteristic of α-helical structure (Figure 8A). In fact, deconvolution of the CD spectrum by 
the CCA method indicated that the percentage of α helix and β-sheet increased from 4 and 16 
to 30 and 33% respectively with the concomitant decrease of non-regular structures (Table 2). 
In contrast, at pH 7.0 the ellipticity decreased in all cases indicating that aggregation 
phenomena on the bilayer observed at pH 5.0 are not so important at pH 7.0 (Figure 8B). 
Furthermore, there is a gradual shift of the minimum to 204 nm and the shoulder at 225 nm is 
not as obvious as it is at pH 5.0. Deconvolution of CD spectrum by CCA method indicated 
that the β-sheet structure disappeared increasing the aperiodic component with no change in 
β-turn. These data indicated a change in the secondary structure of the protein when it 
interacts with acidic phospholipids and a different behaviour at pH 5 and 7. Only at pH 5.0 
does the presence of acidic phospholipids induce a conformational change in the protein that 
increases the α-helix content. On the other hand, the CD spectrum of DpreS-his at pH 5.0 in 
the presence of PC vesicles at a molar protein:lipid ratio of 1:20 is practically 
indistinguishable from that shown  in Figure 8 in the absence of phospholipid vesicles. 
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Aggregation, lipid mixing and release of contents of liposomes. The ability of the protein 
to induce vesicle aggregation was monitored by measuring the variation of the optical density 
at 360 nm (∆OD360) of a suspension of PG liposomes upon incubation with different DpreS-
his concentrations at 37 ºC for 1 h. Upon addition of increasing amounts of protein the OD360 
increased until the protein/lipid molar ratio reached a value of 0.017 and 0.042 at pH 7.0 and 
5.0 respectively and then remained constant (Figure 9A). The optical density values reached 
at pH 5.0 were twice those reached at pH 7.0. On the other hand, DpreS-his did not induce 
any variation of the optical density of neutral phospholipid vesicles, PC, either at pH 5.0 or 
pH 7.0. (Figure 9A). 
Lipid mixing of phospholipid vesicles was followed by the resonance energy transfer 
(RET) assay between the fluorescence probes NBD-PE and Rh-PE incorporated into a lipid 
matrix in which, mixing of phospholipids from labeled and unlabeled liposomes results in a 
decrease in energy transfer between the fluorescent probes 
25
. As observed in Figure 9B, 
DpreS-his domain was able to induce lipid mixing in PG vesicles, both at pH 5.0 and 7.0. 
Although at low protein/lipid molar ratios, up to a value of 0.014, the decrease of RET was 
higher at acidic pH, the results obtained at both pH were almost identical when the protein 
concentration was increased. At both pH values the % RET decreased from 66.5%, in the 
absence of protein, to 6.5–7.0% at the highest DpreS-his concentration. These values 
correspond to approximately a tenfold dilution in the acceptor surface density. Since the mere 
aggregation of the vesicles would not result in such a change in energy transfer 
28
, it could be 
concluded that, under the conditions studied, DpreS-his domains induce the complete fusion 
of acidic vesicles. However, when neutral phospholipids, PC, were employed DpreS-his did 
not induce any effect at both pH assayed (Figure 9B).  
The ability of DpreS-his to destabilize the lipid bilayer has also been studied by 
determining the release of aqueous content from phospholipid vesicles, monitored by 
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measuring the increase in ANTS fluorescence at 520 nm 
26
. As it occurs with aggregation and 
lipid mixing assays, DpreS-his did not show any effect on PC vesicles neither at pH 5.0 nor at 
pH 7.0 (Figure 9C). However, the protein induced instability of PG vesicles and was able to 
induce the release of internal contents of the vesicles in a concentration-dependent manner. 
The maximum effect was achieved at a protein/lipid molar ratio of 0.06 x 10
-2
 at pH 5.0 and 
0.7 x 10
-2 
at pH 7.0 (Figure 9C), ratios much lower than those needed to induce vesicle 
aggregation or lipid mixing. On the other hand, the pH-dependence is higher than that 
observed in vesicle aggregation or lipid mixing, which could be due to the assay sensitivity or 
because an aggregation step is needed in order to destabilize the lipid bilayer, the effect being 
more pronounced at pH 5.0 The maximum fluorescence reached at both pH values, 80–85%, 
is similar to that described for other proteins and did not attain the value obtained when 
liposomes were lysed with the detergent Triton X-100 (100% leakage). 
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DISCUSSION 
 
We have previously shown that the preS domain of HBV is able to interact with and 
destabilize model membrane systems 
17
. In order to extend the studies carried out to other 
members of the hepadnavirus family, a recombinant DHBV preS protein was obtained with 
six histidines at the carboxy-terminal end. The strategy employed yielded 15-20 mg of pure 
and stable protein per liter of culture. Although as a result of the cloning strategy the 
recombinant protein has another 5 extra amino acids, it would be expected that 11 residues 
out of 172 do not promote or modify significantly the interaction of this protein with 
phospholipid vesicles. At least, the extension of six histidines has no effect on the overall 
conformation and destabilization properties of HBV preS domains 
17, 22
. 
The DpreS-his domain, which has an open and mostly non-ordered conformation as 
indicated by fluorescence and circular dichroism spectroscopies, has the ability to interact 
with acidic phospholipid vesicles. In the presence of negatively charged phospholipids, both 
at pH 5.0 and 7.0, the maximum of the emission spectrum of NBD-labeled protein shifted to 
shorter wavelengths, from 548 to 528 nm, which indicates that the region of DpreS-his 
domain to which NBD moiety is bound, probably the amino terminal end, is located in a more 
hydrophobic environment. However, the extent of the observed blue shift is lower than that 
observed with ayw and adr preS subtypes 
17
 indicating that penetration of the N-terminal end 
of DpreS-his into the hydrophobic bilayer is not as deep as that reported for preS subtypes or 
other pore-forming polypeptides 
24, 29
. Binding isotherms provide information about the 
mechanism of the interaction 
30
. They showed two different slopes, with a threshold 
concentration, Cf of 0.7 and 4.5 x 10
-8
 M at pH 5.0 and 7.0, respectively, at which a sharp 
increase in the slope was observed. The existence of such a critical concentration could 
indicate either aggregation of the protein on the surface of the bilayer or the formation of 
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pores with relatively large diameters 
24
. The partition coefficients, reflecting the binding 
constants, were of the order of 10
4
 M
-1
, similar to those described for labeled peptides which 
insert into phospholipid bilayers 
24
 and similar to that obtained with human preS domains 
17
. 
The differences observed between neutral and acidic phospholipids reveal the importance of 
electrostatic interactions in the binding of the DpreS-his domain to phospholipid vesicles. 
Only after ionic interaction between the phospholipid polar head group and the protein, the 
insertion of a region of the later would take place. Moreover, an increase of positive charge as 
the pH decreases would explain the differences observed between the two pH values. 
The results obtained by fluorescence polarization studies corroborate the observed 
phospholipid specificity since DpreS-his is able to modify the thermotropic behaviour of 
acidic phospholipid vesicles but not that of neutral phospholipids. The decrease of the 
transition enthalpy together with the small modification of the transition temperature, are 
typical effects of integral membrane proteins 
31
. The insertion of the recombinant protein into 
the bilayer is stabilized by hydrophobic interaction between the aliphatic chain of the 
phospholipid and the apolar core of the protein as indicated by the fluorescent probe (DPH), 
which provides information of the internal area of the bilayer 
32
. However, an electrostatic 
interaction component must also exist, as indicated by the fluorescence polarization data 
obtained with the TMA-DPH probe that remains anchored to the surface area of the bilayer 
33
. 
When fluorescence polarization data are examined as a function of the protein:lipid ratio, it 
can be concluded that each molecule of protein prevents the transition phase of approximately 
30-50 molecules of phospholipid, suggesting that DpreS-his inserts into the membrane in a 
more tilted manner than HBV preS which prevents the transition phase of only 20 molecules 
of phospholipids 
17
. 
Interaction with liposomes also involves structural alteration of the DpreS-his domain. 
CD spectra indicate the existence of structural changes upon interaction with acidic 
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phospholipids both at pH 7.0 and 5.0. At the latter and at low phospholipid concentration 
protein aggregates are formed probably because of an increase in the density of protein on the 
surface of the bilayer. Such aggregates would produce optical artifacts of differential light 
scattering and differential absorption flattening and hence an increase in the ellipticity values 
34
. When the phospholipid concentration increases up to a protein:lipid ratio of 1:20, there is a 
change in the CD spectrum which must reflect an structural change. This behavior has been 
described for other proteins which interact with phospholipids and the conformational change 
is the result of an increase in the α-helix structure 
35
. This is the case of ferredoxin in the 
presence of negatively charged phospholipids 
36
 which yields a CD spectrum analogous to 
that obtained for DpreS-his. At pH 7.0, the aggregation does not apparently take place but 
there is also some conformational change that modifies the CD spectrum. However, the 
increase in α-helix is not so evident. If we assume that the N-terminal portion of the protein is 
inserted into the bilayer maintaining the same conformation at both pH values, then the C-
terminal end would be the region which increases the helical conformation at pH 5.0 or is able 
to adopt a non-ordered conformation at pH 7.0. However, these data do not allow to know the 
conformation that the inserted region adopts. On the other hand, the appearance of either 
helical or extended conformation as a consequence of the interaction with the bilayer does not 
determine the acquisition of fusogenic properties since both α-helix and β-sheets have been 
described as potential fusogenic domains 
37, 38
. What seems to be more important in terms of 
fusogenic propensity is the flexibility that the polypeptide chain possesses, being able to 
adopt both extended and helical conformations. This is a characteristic feature which has been 
ascribed to some fusogenic peptides, such as in the case of feline leukemia virus 
39
. Moreover, 
the presence of helical and extended structures in the same protein interacting with 
phospholipids is compatible with their involvement in the fusion process since it has been 
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described that some fusogenic peptides can be divided into two domains, an oblique α-helix 
inserted in the water-lipid interface, followed by a turn and a β extended structure in the 
carboxy-terminal end into the hydrophilic phase 
40
.  
Like HBV preS, DpreS-his domain not only interacts with but it is also able to 
destabilize membrane model systems. The interaction of the protein with acidic phospholipid 
vesicles induces their aggregation, as demonstrated by the increase in optical density at 360 
nm, higher at pH 5.0 than 7.0. However, these aggregates do not appear when neutral 
phospholipid vesicles are used which indicates the importance of the electrostatic component 
on the interaction. In the case of acidic phospholipids, the aggregation leads to fusion, as 
demonstrated by lipid mixing studies. The maximum value of aggregation and lipid mixing 
was reached at a protein concentration of 3-5 µM, respectively, considerable higher than that 
needed to break the physical integrity of the vesicles, 0.05 µM at pH 5.0. Thus, fusion is not 
necessary for the release of the aqueous content of the vesicles to take place, just as it occurs 
with the amino-terminal fusogenic peptide of HIV 
41
. The observed dependence of the 
destabilizing capacity of DpreS-his on both phospholipid composition and pH does not 
necessarily preclude or determine a particular fusion mechanism. Thus, both neutral and 
acidic phospholipids have been shown to be specific for the interaction of fusion peptides 
42, 
43
. On the other hand, and although the membrane destabilizing properties are higher at acidic 
pH, the fact that all properties are observed at both pHs and that the differences mostly 
disappear at high protein concentrations, would be in accordance with a pH-independent viral 
infection model. In the case of viruses infecting cells in a pH-dependent manner, such as 
influenza virus, no destabilizing effects at neutral pH were observed 
44
. 
Despite the low similarity of HBV and DHBV preS domains amino acid sequences, 
only 13 identical amino acids (Figure 10A), both proteins present virtually identical 
spectroscopic properties. The fact that they share a very similar hydrophobic profile (Figure 
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10B), points to the importance of the overall three-dimensional structure as well as to its 
conformational flexibility and the distribution of polar and non polar amino acids for the 
expression of their destabilizing properties rather than to a particular amino acid sequence. In 
this sense, it has previously been demonstrated that recombinant polypeptides corresponding 
to a large portion of preS (30-115) of DHBV and heron hepatitis B virus also compete for the 
interaction with the possible cellular receptor, gp180, despite 50% difference between their 
amino acid sequences 
10
. 
In summary, the results presented herein point to the involvement of DpreS in the 
initial steps of DHBV infection. Similar conclusions have been reached from different 
studies. For instance, by carrying out mutations of highly conserved amino acids in two cell 
permeable translocation motifs of DpreS (amino acids 20-31 and 42-53), it has been proposed 
that the preS domains are essential for infectivity 
18
. Taken together with previously reported 
results, the notion that both S and preS regions may participate in the fusion process may be 
extended to other members of the hepadnaviridae family. The involvement of different 
regions of a protein on the membrane fusion step has been proposed for various enveloped 
virus. In Hepatitis C virus, different regions of E2 envelope protein have been implicated in 
the membrane fusion process 
45-47
 and in HIV a hydrophilic region consecutive to the fusion 
peptide participates in the fusion of membranes, increasing the activity and adopting a 
structure in α-helix on the surface of the membrane while the fusogenic peptide adopts β-
structure 
48, 49
, conformations which have been observed for the preS domain and the amino-
terminal end of S, respectively 
13, 17
.  
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TABLES 
 
Table 1. Amino acid composition of DpreS-his. The theoretical composition was 
determined from the amino acid sequence deduced from the cDNA sequence. The 
experimental composition was determined from the amino acid analysis. The numbers of 
Histidine residues was the sum of the 6xHis tag and the DpreS domain (4). The five amino 
acids added by the cloning procedure were: 1 Thr, 2 Ala, 1 Leu and 1 Glu. N.D (not 
determined).  
 
 
 
Theoretic Experimental 
Asx 11 11 
Thr 12+1 12 
Ser 7 6 
Glx 27+1 28 
Pro 22 22 
Gly 12 12 
Ala 8+2 10 
Val 6 6 
Met 3 3 
Ile 7 7 
Leu 15+1 16 
Tyr 2 2 
Phe 2 2 
His 4+6 10 
Lys 9 9 
Arg 9 9 
Trp 4 N.D. 
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Table 2. Secondary structure of DpreS-his under different conditions calculated from 
the CD spectra according to the CCA method 
23
.  
 
 
 
Secondary Structure (%) 
α-Helix β-Sheet β-Turn Aperiodic 
DpreS-his, pH 
7.0 
4 16 29 51 
DpreS-his:PG 
(1:50) pH 7.0 
7 0 29 64 
DpreS-his:PG 
(1:50) pH 5.0 
30 33 2 35 
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FIGURE LEGENDS 
 
Figure 1. SDS-PAGE of DpreS-his purification steps.  E. coli HMS174 cells (DE3) (A) and 
Tuner cells (B) were transformed with pET21b-DpreS. Lane 1, protein markers. Lane 2, 
transformed cells before induction. Lane 3, transformed cells after 4 h (A) and 2h (B) IPTG 
induction. Lane 4, cell pellet. Lane 5, supernatant obtained after disruption of cells in 10 mM 
Imidazol buffer. Lane 6, protein not retained in the Ni-NTA column. Lane 7, proteins washed 
from the Ni-NTA column with 10 mM Imidazol (A) or 30 mM Imidazol (B). Lane 8, pure 
protein after eluting with 200 mM Imidazol buffer. 
 
Figure 2. Circular dichroism spectra of DpreS-his. (A) Far-UV CD spectrum. Protein 
concentration was 0.1 mg/ml and cell pathlength 0.1 cm. (B) Near-UV CD spectra. Protein 
concentration was 1 mg/ml and cell pathlength 1 cm. The buffer employed was 10 mM 
MOPS pH 7.0. 
 
Figure 3. Fluorescence emission spectra of DpreS-his. The protein concentration was 0.05 
mg/mL in 10 mM MOPS pH 7.0. The spectra were obtained upon excitation at 275 nm (—) 
and 295 nm (– –). The contribution of tyrosine residues to the emission spectra of the protein 
(·····) is calculated as described in Materials and methods. 
 
Figure 4. Effect of PG and PC on the fluorescence spectrum of NBD-DpreS-his at pH 5.0 (A) 
and pH 7.0 (B). Spectrum of NBD-DpreS-his alone (·····) and in presence of PG  (– –) or PC 
vesicles (—) at a lipid:protein molar ratio of 4600:1. The excitation wavelength was 467 nm 
and the protein concentration was 0.03-0.06 µM. 
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Figure 5. Fluorescence increase at 530 nm of NBD-DpreS-his upon addition of PG (●) or PC 
vesicles (○) at pH 5.0 (A) or pH 7.0 (B). The excitation wavelength was set at 467 nm. 
Protein concentration was 0.03-0.06 µM. The fluorescence values refer to those obtained 
without lipids.  
 
Figure 6. Binding isotherms of NBD-DpreS-his to PG vesicles at pH 5.0 (A) or pH 7.0 (B). 
From the increments in fluorescence intensity at 530 nm, Xb* and Cf are calculated as 
described in Materials and methods. Partition coefficients were calculated from the initial 
slope of the corresponding binding isotherm (insets). 
 
Figure 7. Fluorescence depolarization of DPH-labeled (A and B) and TMA-DPH-labeled (C 
and D) DMPG vesicles with increasing temperatures in the presence of DpreS-his at different 
protein/lipid molar ratios at pH 5.0 (A and C) and 7.0 (B and D). Phospholipids vesicles (0.14 
mM) labeled with DPH (probe/phospholipid weight ratio 500/1) and TMA-DPH 
(probe/phospholipid weight ratio 100/1) in absence of protein (■) and incubated with DMPG 
at a molar protein:phospholipid ratio of 1:100 (●) and 1:20 (○). Insets represent the 
fluorescence polarization at 37.5 °C as a function of the protein/lipid molar ratio.  
 
Figure 8. Effect of PG vesicles on the CD spectra of DpreS-his. The spectra were recorded 
both in the absence (■) and in presence of PG vesicles, at pH 5.0 (A) and 7.0 (B) after 
incubating at 37 °C for 1 h. The protein concentration was 0.5 µM and the protein/lipid molar 
ratios were 1:5 (●), 1:10 (○) and 1:20 (∆). 
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Figure 9. Aggregation (A), lipid mixing (B) and leakage of aqueous content (C) of PG 
(circles) and PC (squares) vesicles induced by DpreS-his at pH 7.0 (○, □) and 5.0 (●,■).The 
final phospholipid concentration was 60 µM (A) and 0.14 mM (B and C). 
 
Figure 10. Amino acid sequence (A) and hydrophobicity profile (B) of the human preS 
domain subtype ayw (—) and DpreS (---). The hydrophobicity profile has been calculated 
according to the scale of hydrophobicity proposed by Eisenberg 
50
. 
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